Parvovirus H-1 (ParvOryx) in Patients With Metastatic Inoperable Pancreatic Cancer
Status:
Completed
Trial end date:
2018-05-01
Target enrollment:
Participant gender:
Summary
Investigation on safety, tolerability and efficacy of parvovirus H-1 (ParvOryx) in subjects
suffering from metastatic, inoperable pancreatic cancer with at least one hepatic metastasis.